Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Over the past 24 hours, Ethereum's (CRYPTO: ETH) price has fallen 6.84% to $1,886.01. This continues its negative trend over the past week where it has experienced a 3.0% loss, moving from $1,951.32 to its current price.
PTC Therapeutics' Translarna loses EU conditional approval, but countries may allow continued use. PTC submitted four FDA applications, all under review.
Sensei Biotherapeutics' solnerstotug shows a 14% ORR in PD-(L)1 resistant tumors and remains well tolerated in early trial data from its Phase 1/2 study.
Alibaba's stock has rebounded by 60% this year, adding $100 billion to its valuation, after a rallying call from Jack Ma in 2023 and a renewed focus on AI and core businesses.
Palatin's PL8177 showed promising ulcerative colitis trial results, with strong clinical response rates. FDA granted orphan status to its obesity drug PL7737.
Mitsui Sumitomo Insurance will acquire 15% stake in W.R. Berkley Corp. through investment and voting agreement. Berkley family will retain full ownership.
Leading chipmakers and packagers, including TSMC and Intel, have slowed expansions in Japan and Malaysia due to weaker demand for older chips and tariff uncertainties.
Lexicon Pharmaceuticals granted Novo Nordisk exclusive rights to develop LX9851, an oral obesity drug, with potential milestone payments of up to $1 billion.
